QCLS

Q/C Technologies Inc. Common Stock (QCLS)

Stock · NASDAQ · Health Care

$2.35as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Resistance level
$3.71
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances

Q/C Technologies Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • QCLS
    Q/C Technologies Inc. Common Stock
    $2.37
    ▲ 0.00%
    Market cap $21.60MP/E
  • CDIO
    Cardio Diagnostics Holdings Inc. Common stock
    $1.84
    ▼ 1.60%
    Market cap $4.85MP/E
    $0.97$7.91
  • BMRA
    Biomerica Inc. Common Stock
    $2.14
    ▲ 1.67%
    Market cap $4.73MP/E
    $1.45$3.31
  • VRAX
    Virax Biolabs Group Limited Ordinary Shares
    $2.82
    ▼ 4.08%
    Market cap $2.34MP/E
    $2.5$21.75
  • IMDX
    Insight Molecular Diagnostics Inc. Common Stock
    $4.16
    ▼ 3.03%
    Market cap $162.42MP/E
    $2.33$8.51
  • TKNO
    Alpha Teknova Inc. Common Stock
    $7.13
    ▼ 2.46%
    Market cap $284.15MP/E
    $1.91$7.84
  • ACHV
    Achieve Life Sciences Inc. Common Shares
    $8.09
    ▼ 1.16%
    Market cap $648.81MP/E
    $2.62$8.61

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
612.0K
Total value held
$2.02M
Institutional holders
17
Top holders this quarter
  • Unknown211.4K
  • Unknown126.2K
  • Unknown78.0K
  • Unknown50.0K
  • Unknown47.4K
  • Unknown37.5K
  • Unknown22.4K
  • Unknown19.1K
  • Unknown12.9K
  • Unknown3.5K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.